Now that Viridian Therapeutics Inc’s volume has hit 0.85 million, investors get a glimpse of its size.
On Friday, Viridian Therapeutics Inc (NASDAQ: VRDN) was -4.10% down from the session before settling in for the closing price of $18.78. A 52-week range